American Medical Association

SHERPA: White

People

  1. Berger
    Berger
  2. Ladanyi
    Ladanyi
  3. Solit
    Solit
  4. Arcila
    Arcila
  5. Joseph
    Joseph
  6. Mandelker
    Mandelker
  7. Offit
    Offit
  8. Robson
    Robson
  9. Stadler
    Stadler
  10. Walsh
    Walsh

Groups

  1. Department of Medicine (9)
  2. Early Drug Development Service (9)
  3. Solid Tumor Oncology Division (9)
  4. GSK Faculty (7)
  5. Human Oncology and Pathogenesis Program (7)
  6. Genitourinary Oncology Service (6)
  7. Tow Center for Developmental Oncology (TCDO) (6)
  8. Center for Pancreatic Cancer Research (5)
  9. Survivorship Research (5)
  10. Breast Medicine Service (4)
Search Within
  1. "David Hyman"
Formats
  1. Journal Article (9)
Groups
  1. Department of Medicine (9)
  2. Early Drug Development Service (9)
  3. Solid Tumor Oncology Division (9)
  4. GSK Faculty (7)
  5. Human Oncology and Pathogenesis Program (7)
  6. Genitourinary Oncology Service (6)

More Groups

People
  1. David Hyman (9)
  2. Ahmet Zehir (5)
  3. David Solit (5)
  4. Marc Ladanyi (5)
  5. Michael Berger (5)
  6. Liying Zhang (4)

More People

Years
  1. 2020 (1)
  2. 2019 (1)
  3. 2018 (3)
  4. 2017 (2)
  5. 2016 (1)
  6. 2012 (1)
Publications
  1. JAMA Oncology (7)
  2. JAMA - Journal of the American Medical Association (2)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Development of genome-derived tumor type prediction to inform clinical cancer care
    Journal Article

    Penson, A.; Camacho, N.; Zheng, Y.; Varghese, A. M.; Al-Ahmadie, H.; Razavi, P.; Chandarlapaty, S.; Vallejo, C. E.; Vakiani, E.; Gilewski, T.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Use, safety, and efficacy of single-patient use of the US Food and Drug Administration Expanded Access Program
    Journal Article

    Feit, N. Z.; Goldman, D. A.; Smith, E.; Deighan, J.; Iasonos, A.; Zivanovic, O.; Hyman, D. M.
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • Prevalence of clonal hematopoiesis mutations in tumor-only clinical genomic profiling of solid tumors
    Journal Article

    Ptashkin, R. N.; Mandelker, D. L.; Coombs, C. C.; Bolton, K.; Yelskaya, Z.; Hyman, D. M.; Solit, D. B.; Baselga, J.; Arcila, M. E.; Ladanyi, M.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma
    Journal Article

    Carlo, M. I.; Mukherjee, S.; Mandelker, D.; Vijai, J.; Kemel, Y.; Zhang, L.; Knezevic, A.; Patil, S.; Ceyhan-Birsoy, O.; Huang, K. C.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Vemurafenib for BRAF V600-mutant Erdheim-Chester disease and Langerhans cell histiocytosis analysis of data from the histology-independent, phase 2, open-label VE-BASKET study
    Journal Article

    Diamond, E. L.; Subbiah, V.; Lockhart, A. C.; Blay, J. Y.; Puzanov, I.; Chau, I.; Raje, N. S.; Wolf, J.; Erinjeri, J. P.; Torrisi, J.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Journal Article

    Mandelker, D.; Zhang, L.; Kemel, Y.; Stadler, Z. K.; Joseph, V.; Zehir, A.; Pradhan, N.; Arnold, A.; Walsh, M. F.; Li, Y.; more...
    JAMA - Journal of the American Medical Association (2017)

    Fulltext@MSK | Save
  • The molecular landscape of recurrent and metastatic head and neck cancers insights from a precision oncology sequencing platform
    Journal Article

    Morris, L. G. T.; Chandramohan, R.; West, L.; Zehir, A.; Chakravarty, D.; Pfister, D. G.; Wong, R. J.; Lee, N. Y.; Sherman, E. J.; Baxi, S. S.; more...
    JAMA Oncology (2017)

    Fulltext@MSK | Save
  • Germline variants in targeted tumor sequencing using matched normal DNA
    Journal Article

    Schrader, K. A.; Cheng, D. T.; Joseph, V.; Prasad, M.; Walsh, M.; Zehir, A.; Ni, A.; Thomas, T.; Benayed, R.; Ashraf, A.; more...
    JAMA Oncology (2016)

    Fulltext@MSK | Save
  • Unwrapping the implications of BRCA1 and BRCA2 mutations in ovarian cancer
    Journal Article

    Hyman, D. M.; Spriggs, D. R.
    JAMA - Journal of the American Medical Association (2012)

    Fulltext@MSK | Save